Emory University a Research News
  a MARCH 18, 2008 a
a a

We are pleased to send you this twice-monthly newsletter about research in Emory's Woodruff Health Sciences Center. The newsletter will highlight articles about interesting and significant research projects and discoveries from Emory faculty. More stories are available on our research website.

David S. Stephens, MD, Vice President for Research, WHSC
a a
Gold Nanoparticles  
Gold Nanoparticle Probes May Allow Earlier Cancer Detection

Using tiny gold particles embedded with dyes, Emory and Georgia Tech researchers have shown they can identify tumors under the skin of a living animal. These tools may allow doctors to detect and diagnose cancer earlier and less invasively. Read more . . .
a a
Michael Zwick  
A Chip Off the Old Genomic Block

For geneticist Michael Zwick, it's not just about
knowing where to look for autism susceptibility
genes, it's also about knowing how. Finding
these genes could lead to better diagnostic tests
and ultimately a treatment for autism. Being able
to find them using Zwick's new resequencing
technology could help personalize medicine for
everyone. Read more . . .
a a
Angiogenesis May Hold Key to Efficient Treatment of Leprosy

Scientists are hoping to treat leprosy by taking advantage of one of its most distinctive characteristics--the richly vascularized skin lesions that typify this disease. Led by Jack Arbiser, MD, PhD, professor of dermatology at Emory University School of Medicine. Read more . . .
a a
Better Childhood Nutrition Increases Productivity, Emory Study Finds

Feeding very young children a high-energy, high-protein supplement leads to increased economic productivity in adulthood, especially for men, according to a study by Emory University public health researcher Reynaldo Martorell, PhD, and a team of economists. Read more . . .
a a
Novel Anti-Cancer Strategy Yields Promising Results in Mouse Research

Researchers at Emory School of Medicine have developed a novel anti-tumor compound that represents a distinct strategy: targeting one of the most important "intercept points" for cancer cells. The idea behind the intercept point strategy, which is being tested in early clinical trials in human patients, is to shut down the transmission of a large number of growth signals in cancer cells at once. Read more . . .
a a
First Line of Defense Against Colds and Flu

It may not protect against a bad case of flu, but glutathione may just be the answer to fighting off a mild viral load of influenza. That's what the manufacturers of Sucrets Defense are counting on, based on research by an Emory biochemist. Glutathione is the active ingredient in the popular over-the-counter cold and flu remedy that promises to boost the immune system and fight off infection. Read more . . .
Woodruff Health Sciences Center